AO-1535 is a semisynthetic monoglycosylceramide derived from O-glycosilated sphingosine. It has been shown to inhibit superoxide production by macrophages suggesting a potential clinical application of AO 1535 in the treatment of inflammatory dermatoses. References: Spampinato G, Messina L, Malaguarnera L, Arcidiacono A, Giuffrida MA, Guarniera E, Geremia E, Rastrelli A, Messina A. AO 1535 inhibits O2- production by human macrophages. Immunopharmacology. 1992 Jul-Aug;24(1):25-30. PubMed PMID: 1333456.

纯度：≥98%

CAS：87178-48-1